Ibuprofen Dr.Max

Ibuprofen, the active ingredient in Ibuprofen Dr.Max, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats mild to moderate pain, fever and inflammation in adults and children. GNH USA supplies Ibuprofen Dr.Max as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen is an NSAID that reduces inflammation and pain by inhibiting prostaglandin synthesis.

Mild to moderate pain: provides analgesic relief for headaches, dental pain and musculoskeletal discomfort. Fever: lowers elevated body temperature. Inflammatory conditions: reduces swelling in arthritis and other inflammatory disorders.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or mild itching. - Elevated blood pressure in susceptible individuals.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation. - Acute renal impairment or failure. - Severe allergic reactions such as anaphylaxis. - Hepatotoxicity with elevated liver enzymes. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiovascular events including myocardial infarction in high‑risk patients.

Before using Ibuprofen, consider the following safety measures.

Assess gastrointestinal risk: evaluate history of ulcers or bleeding. Monitor renal function: avoid in patients with severe kidney disease. Avoid in third‑trimester pregnancy: discuss alternatives with the prescriber. Use lowest effective dose: limit duration to reduce adverse events. Store at ambient temperature: keep in the original container, protect from moisture and heat.

Ibuprofen may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Concurrent NSAIDs or aspirin: heightened gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): elevated hemorrhage risk.

Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: possible reduction in renal function. - Lithium: NSAIDs can raise lithium serum concentrations. - Methotrexate: co‑administration may increase methotrexate toxicity.